Authors: LANCE WR

Citation: Wr. Lance, NEW PHARMACEUTICALS FOR USE IN WILD AND EXOTIC SPECIES BEYOND 2000 - THE CHALLENGES FOR INDUSTRY AND FDA, Veterinary and human toxicology, 40, 1998, pp. 22-23

Authors: MILLER MW WILD MA LANCE WR

Citation: Mw. Miller et al., EFFICACY AND SAFETY OF NALTREXONE HYDROCHLORIDE FOR ANTAGONIZING CARFENTANIL CITRATE IMMOBILIZATION IN CAPTIVE ROCKY-MOUNTAIN ELK (CERVUS-ELAPHUS NELSONI), Journal of wildlife diseases, 32(2), 1996, pp. 234-239

Authors: LANCE WR

Citation: Wr. Lance, COMPOUNDING IN EXOTIC ANIMAL PRACTICE, Journal of the American Veterinary Medical Association, 205(2), 1994, pp. 213-214

Authors: LANCE WR

Citation: Wr. Lance, PHARMACEUTICAL TOOLS FOR WILDLIFE MEDICINE AND MANAGEMENT - 2000 AND BEYOND, Veterinary and human toxicology, 35, 1993, pp. 5-7

Authors: LANCE WR

Citation: Wr. Lance, EXTRALABEL DRUG-USE - THE LIFEBLOOD OF ZOO ANIMAL AND WILDLIFE MEDICINE, Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1649-1650

Authors: LOEW FM WELSER J LANCE WR FRANCISFLOYD R JOHNSON DE CLELAND J TESKE R RITTER L MORIN MJ GLOYD J MACOMBER E LEIN D SOJKA NJ LAUTNER B REID J

Citation: Fm. Loew et al., USE OF FDA-APPROVED DRUGS IN VETERINARY-MEDICINE - PROHIBITIONS, PREROGATIVES, AND RESPONSIBILITIES .2., Journal of the American Veterinary Medical Association, 202(10), 1993, pp. 1654-1658